Picture of Applied Molecular Transport. logo

AMTI — Applied Molecular Transport. News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Applied Molecular Transport Inc. expected to post a loss of 60 cents a share - Earnings Preview

* Applied Molecular Transport Inc.  AMTI.OQ   AMTI.O  is
expected to show a no change in quarterly revenue when it
reports results on August 9 (estimated). 
​* Refinitiv's mean analyst estimate for Applied Molecular
Transport Inc. is for a loss of 60 cents per share. For the same
quarter last year, the company reported a loss of $1.11 per
share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Applied
Molecular Transport Inc. is $74.5​, about 60% above​ its last
closing price of $29.77. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.75       -0.75      -0.58     Beat    22.7
 Dec. 31 2020  -0.51       -0.47      -0.38     Beat    20
 Sep. 30 2020  -0.41       -0.41      -0.48     Missed  -17.1​
 Jun. 30 2020  -0.38       -0.38      -1.11     Missed  -192.1
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 6 at 12:21 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Applied Molecular Transport.

See all news